表紙
市場調査レポート

BioTech Tools s.a. :製品パイプライン分析

BioTech Tools s.a. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 321947
出版日 ページ情報 英文 19 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
BioTech Tools s.a. :製品パイプライン分析 BioTech Tools s.a. - Product Pipeline Review - 2015
出版日: 2015年05月13日 ページ情報: 英文 19 Pages
概要

BioTech Tools s.a. は、免疫反応に関連した疾患の診断および治療効果を高めることに力を入れている、臨床病期に対応したバイオ製薬会社です。特に、呼吸器系および食物アレルギーのための免疫療法薬の開発と商品化に取り組んでおり、花粉症や家ダニによる喘息、ピーナッツアレルギー治療に活用されています。

当レポートでは、BioTech Tools s.a.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

BioTech Tools s.a.の基本情報

BioTech Tools s.a.の概要

  • 主要情報
  • 企業情報

BioTech Tools s.a.:R&Dの概要

  • 主な治療範囲

BioTech Tools s.a.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • 併用療法モダリティ

BioTech Tools s.a.:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

BioTech Tools s.a.:薬剤プロファイル

  • gpASIT + TM
  • hdm-ASIT
  • pnut-ASIT

BioTech Tools s.a.:パイプライン分析

  • 投与経路別
  • 分子タイプ別

BioTech Tools s.a.:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07087CDB

Summary

Global Markets Direct's, 'BioTech Tools s.a. - Product Pipeline Review - 2015', provides an overview of the BioTech Tools s.a.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of BioTech Tools s.a.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of BioTech Tools s.a. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of BioTech Tools s.a.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the BioTech Tools s.a.'s pipeline products

Reasons to buy

  • Evaluate BioTech Tools s.a.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of BioTech Tools s.a. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the BioTech Tools s.a.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of BioTech Tools s.a. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of BioTech Tools s.a.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of BioTech Tools s.a. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • BioTech Tools s.a. Snapshot
    • BioTech Tools s.a. Overview
    • Key Information
    • Key Facts
  • BioTech Tools s.a. - Research and Development Overview
    • Key Therapeutic Areas
  • BioTech Tools s.a. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • BioTech Tools s.a. - Pipeline Products Glance
    • BioTech Tools s.a. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • BioTech Tools s.a. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • BioTech Tools s.a. - Drug Profiles
    • gp-ASIT
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hdm-ASIT
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pnut-ASIT
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • BioTech Tools s.a. - Pipeline Analysis
  • BioTech Tools s.a. - Pipeline Products by Route of Administration
  • BioTech Tools s.a. - Pipeline Products by Molecule Type
  • BioTech Tools s.a. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • BioTech Tools s.a., Key Information
  • BioTech Tools s.a., Key Facts
  • BioTech Tools s.a. - Pipeline by Indication, 2015
  • BioTech Tools s.a. - Pipeline by Stage of Development, 2015
  • BioTech Tools s.a. - Monotherapy Products in Pipeline, 2015
  • BioTech Tools s.a. - Phase II, 2015
  • BioTech Tools s.a. - Preclinical, 2015
  • BioTech Tools s.a. - Pipeline by Route of Administration, 2015
  • BioTech Tools s.a. - Pipeline by Molecule Type, 2015

List of Figures

  • BioTech Tools s.a. - Pipeline by Top 10 Indication, 2015
  • BioTech Tools s.a. - Pipeline by Stage of Development, 2015
  • BioTech Tools s.a. - Monotherapy Products in Pipeline, 2015
  • BioTech Tools s.a. - Pipeline by Top 10 Route of Administration, 2015
  • BioTech Tools s.a. - Pipeline by Top 10 Molecule Type, 2015
Back to Top